Data & Updates

We are excited to announce that we are working with BS Partnership Ltd to implement our quality management system for ISO 13485 compliance. Completion of this process will enable ProColl collagen to be integrated into medical devices. We expect to have a successful audit completed by the end of this summer.

Research by Sheffield University using ProColl’s acid soluble collagen demonstrated its superior performance over gelatin for cell culture. Using ProColl’s collagen resulted in cells which had significantly better levels of key bone-growth markers. Calcium content and DNA were significantly higher when cultured on ProColl’s collagen than on gelatin. Also, significantly lower collagen production occurred since […]

Endotoxins unfortunately are often found as contaminants of protein products derived from bioprocesses and because of their strong biological effects at very low concentrations within the human body they are of extreme concern for clinicians and the pharmaceutical industry. In patients even in small quantities endotoxins can result in fever, inflammation, sepsis, tissue damage and […]